- Fee assured
- Verified this account
- Gynaecological oncology
Dr Ian Harley BSc MD FRCOG
Ian Harley is a Consultant Gynaecologist and Gynaecological Oncologist at the Northern Ireland Regional Cancer Centre, Belfast City Hospital.
He graduated in Medicine from the Queen’s University of Belfast in 1993, entering the Royal College of Obstetricians and Gynaecologists (RCOG) training programme in the Northern Ireland Deanery in 1995. In 2003-2006 he left Northern Ireland to train as a Gynaecological Oncologist at the University of Toronto, Ontario, Canada.
Ian was awarded a Postgraduate Medical Doctorate (MD) from the Queen’s University, Belfast in 2008 for his original research into hereditary ovarian cancer. He was appointed a Consultant Gynaecological Oncologist at the Belfast City Hospital in 2008. In 2013 he was awarded an Honorary Lectureship at the Queen’s University Belfast and is a member of the Ovarian Cancer research group at the University’s Centre for Cancer Research and Cell Biology. He is the University of West Indies(UWI) / International Gynae. Cancer Society overseas mentor and an extern examiner for the UWI gynaecological oncology Fellowship.
Ian’s interests include Minimal Access Surgery in Gynaecology and Oncology, Hereditary Gynaecological Cancers and Translational Research in Ovarian Cancer. He is a member of Faculty for the Olympus Minimal Access Surgery Fellowship. He has many journal publications and presents at regional, national and international meetings.
Despite all of the above, Ian’s main interest is his family – wife Kim and two sons: Angus and Callum. Ian’s passion - spending as much free time sailing, travelling and skiing with his family and friends.
Areas of interest
Gynaecological oncology; Gynaecology; Minimal access / invasive surgery; Menstrual disorders; Post-menopausal bleeding; Cancer prevention; Colposcopy; menorrhagia; BRCA; Familial Cancer
Anaesthetists worked with
- Dr Jonathan Adams Not Fee Assured
- Dr Rachel E Deyermond Fee Assured
Current NHS consultant posts held
Consultant Gynaecologist / Gynaecological Oncologist, Belfast City Hospital, Belfast Northern Ireland
Clinical Outcomes in Gynaecological Oncology
Minimal Access Surgery in Gynaecological Oncology
Hereditary Gynaecological Cancers
Sentinel Lymph Nodes in Gynaecological Oncology
Ovarian cancer prevention and biomarker discovery for ovarian cancer screening
Family, Music, Sailing, Skiing, Gardening
Defining the Molecular Evolution of Extrauterine High Grade Serous Carcinoma
Gynecologic Oncology – Submitted for Peer Review April 2019
Pathological chemotherapy response score predicts survival in patients with advanced tubo-ovarian high-grade serous carcinoma receiving neoadjuvant chemotherapy: systematic review and meta-analysis of individual patient data
Accepted for Publication Gynaecologic Oncology April 2019
Survival from stage 1B1 cervical cancer has not been impacted by the introduction of minimal access surgery in the UK
BJOG July 2019; 126(8):956-959
Early catheter removal following laparoscopic radical hysterectomy for cervical cancer: assessment of a new bladder care protocol.
J Obstet Gynaecol. 2017 Oct;37(7):970-972.
Postpartum Ovarian Vein Thrombosis
Postpartum ovarian vein thrombosis.
The Obstetrician & Gynaecologist 2016;18:291–9.
The Molecular and Genetic Basis of Inherited Cancer Risk in Gynaecology
James P Beirne, Gareth W Irwin, Stuart McIntosh, Ian JG Harley, D Paul Harkin
The Obstetrician and Gynaecologist 2015, 17(4):233-41
Cervical Adenocarcinoma Secondary to Primary Vulval Paget’s Disease: An unusual form of retrograde spread.
Histology. 2015 Jun; 66(7), 1031-034.
A rare case of HPV-negative keratinizing cervical squamous cell carcinoma.
Int J of Gynaecol Path, 2015 Mar; 34(2), 208-212.
The Distal Fallopian Tube as the Origin of Pelvic High-Grade Serous Ovarian Carcinoma.
Harley IJG, Quinn JE, Beirne JP, McCluggage WG
Scientific Impact Paper, Royal College of Obstetricians and Gynaecologists, London, England.
RCOG Press 18th November 2014
BRCA1 Immunohistochemical Staining as a Prognostic Indicator in Uterine Serous Carcinoma.
Int J Gynecol Cancer. 2013 Jan;23(1):113-8.
Role of Adjuvant Radiotherapy in Granulosa Cell Tumors of the Ovary.
Int J Radiat Oncol Biol Phys. 2011 Mar 1;79(3):770-4
Composite cervical adenocarcinoma composed of adenoma malignum and gastric type adenocarcinoma (dedifferentiated adenoma malignum) in a patient with Peutz Jeghers syndrome.
J Clin Pathol. 2010 Oct;63(10):935-41
Single nucleotide polymorphisms - variation on a theme.
Harley IJ, Narod SA.
BJOG. 2009 Nov;116(12):1556-7
A promoter sequence polymorphism nt-93 in MLH1 and increased risk of ovarian cancer.
Harley I, McLaughlin J, Murphy J, Ping S, Rosen B, Narod SA
Gynecologic Oncol Jun 109(3):384-7 2008
Courses offered to GPs
BRCA Mutations – reducing mortality from Ovarian Cancer.
What’s New In Gynaecological Oncology?
Opportunistic Salpingectomy for Ovarian Cancer Prevention
Hereditary Gynaecological Malignancies
“It’s in your Genes – the Genetics of Cancer”
Pathogenesis of Ovarian Cancer: New Directions
Cervical Cancer and HPV
- MB BCh BAO The Queen's University of Belfast 1964
- BSc The Queen's University of Belfast 1988
- MRCOG Royal College of Obstetricians and Gynaecologists 1999
- FRCOG Royal College of Obstetricians and Gynaecologists 2013
- Doctorate of Medicine (MD) The Queen's University of Belfast 2008
- Gynaecological Oncology Fellowship / Subspecialist Training University of Toronto, Ontario, Canada (2003-2006) 2006
- Gyn. Oncology Subspecialist Training Royal College of Obstetricians and Gynaecologists 2008
Reference number 4040992
Details of entry to specialist register
- CCST / PMETB GMC Specialist register for Obstetrics and Gynaecology, 2008
- CCST / PMETB GMC Specialist register Subspecialist in Gynaecological Oncology, 2008
Affiliations / memberships
Royal College of Obstetricians and Gynaecologists
Irish Society of Gynaecological Oncology
European Society of Gynaecological Oncology
International Gynaecological Cancer Society
- Ulster Independent Clinic, 245 Stranmillis...
- 09:00 - 13:00
- 028 9066 1212
- Ulster Independent Clinic, 245 Stranmillis...
- 18:00 - 21:00
- 028 9066 1212
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.
In the event of an urgent query following treatment, Bupa members should use the following contact details
Ulster Independent Clinic
028 9066 1212